Cannara Biotech Inc. (LOVE.V) TSXV

1.68

-0.02(-1.18%)

Updated at December 24 12:58PM

Currency In CAD

Valuation

Market Cap61.25M
Enterprise Value102.95M
P/E Ratio9.9
PEG Ratio0.74
Price/Sales Ratio1.5
Price/Book Ratio1.56
Enterprise/Revenue1.82
Enterprise/EBITDA6.91

Fiscal Year

Fiscal YearAugust 31, 2024
Most Recent QuarterAugust 31, 2025

Profitability

Profit Margin0.15
Operating Margin0.21

Management Effectiveness

Return On Assets0.09
Return On Equity0.17

Income Statement

Revenue107.32M
Revenue/Share1.12
Gross Profit47.22M
EBITDA28.18M
Net Income13.08M
Diluted EPS0.14

Balance Sheet

Total Cash14.36M
Total Cash/Share0.16
Total Debt41.58M
Total Debt/Equity0.48
Current Ratio2.43
Book Value Per Share1.08

Price History

52-Week Change115.38
52-Week High1.99
52-Week Low0.69
Moving Average 50 Days1.7
Moving Average 200 Days1.57

Statistics

Average Volume46,760
Shares Outstanding90.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateFebruary 13, 2023